Cardiology
SGLT2 Inhibitors vs GLP-1 Receptor Agonists: What Cardiovascular Evidence Shows
A randomized-trial review favors SGLT2 inhibitors for heart failure hospitalization, while mortality differences from GLP-1 receptor agonists remain less certain.
Dr. Abu Bakar · October 11, 2026 · 6 min